S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis

S. Y. Kim,Y S Hong,E.K. Shim,S.-Y. Kong,A. Shin,J.-Y. Baek,K. H. Jung

S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis

2013

S. Y. Kim
Y S Hong
E.K. Shim
S.-Y. Kong
A. Shin
J.-Y. Baek
K. H. Jung

S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis

Keywords:

Phases of clinical research
Pharmacogenetics
Medicine
Colorectal cancer
Pathology
Pharmacogenetic Analysis
Camptothecin
Irinotecan
Oxaliplatin
Tegafur

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations